381 related articles for article (PubMed ID: 31052499)
1. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.
Pleet ML; DeMarino C; Stonier SW; Dye JM; Jacobson S; Aman MJ; Kashanchi F
Viruses; 2019 May; 11(5):. PubMed ID: 31052499
[TBL] [Abstract][Full Text] [Related]
2. Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.
Pleet ML; Erickson J; DeMarino C; Barclay RA; Cowen M; Lepene B; Liang J; Kuhn JH; Prugar L; Stonier SW; Dye JM; Zhou W; Liotta LA; Aman MJ; Kashanchi F
J Infect Dis; 2018 Nov; 218(suppl_5):S365-S387. PubMed ID: 30169850
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicle storm during the course of Ebola virus infection in primates.
Vucetic A; Lafleur A; Côté M; Kobasa D; Chan M; Alvarez F; Piccirillo C; Dong G; Olivier M
Front Cell Infect Microbiol; 2023; 13():1275277. PubMed ID: 38035334
[TBL] [Abstract][Full Text] [Related]
4. The Role of Exosomal VP40 in Ebola Virus Disease.
Pleet ML; DeMarino C; Lepene B; Aman MJ; Kashanchi F
DNA Cell Biol; 2017 Apr; 36(4):243-248. PubMed ID: 28177658
[TBL] [Abstract][Full Text] [Related]
5. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
6. Host Factors Involved in Ebola Virus Replication.
Rasmussen AL
Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692
[TBL] [Abstract][Full Text] [Related]
7. Impact of Ebola virus nucleoprotein on VP40 virus-like particle production: a computational approach.
Liu X; Stahelin RV; Pienaar E
Commun Biol; 2024 May; 7(1):634. PubMed ID: 38796621
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.
Okumura A; Rasmussen AL; Halfmann P; Feldmann F; Yoshimura A; Feldmann H; Kawaoka Y; Harty RN; Katze MG
J Virol; 2015 Oct; 89(20):10399-406. PubMed ID: 26246577
[TBL] [Abstract][Full Text] [Related]
9. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM
PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933
[TBL] [Abstract][Full Text] [Related]
10. Ebolavirus VP35 is a multifunctional virulence factor.
Leung DW; Prins KC; Basler CF; Amarasinghe GK
Virulence; 2010; 1(6):526-31. PubMed ID: 21178490
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.
Han Z; Sagum CA; Takizawa F; Ruthel G; Berry CT; Kong J; Sunyer JO; Freedman BD; Bedford MT; Sidhu SS; Sudol M; Harty RN
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768865
[TBL] [Abstract][Full Text] [Related]
12. Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.
Pleet ML; Mathiesen A; DeMarino C; Akpamagbo YA; Barclay RA; Schwab A; Iordanskiy S; Sampey GC; Lepene B; Nekhai S; Aman MJ; Kashanchi F
Front Microbiol; 2016; 7():1765. PubMed ID: 27872619
[TBL] [Abstract][Full Text] [Related]
13. ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.
Han Z; Madara JJ; Liu Y; Liu W; Ruthel G; Freedman BD; Harty RN
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S138-45. PubMed ID: 25786915
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
15. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles.
Nanbo A; Maruyama J; Imai M; Ujie M; Fujioka Y; Nishide S; Takada A; Ohba Y; Kawaoka Y
PLoS Pathog; 2018 Jan; 14(1):e1006848. PubMed ID: 29338048
[TBL] [Abstract][Full Text] [Related]
16. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
17. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
[TBL] [Abstract][Full Text] [Related]
18. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
19. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Ebola virus VP40 matrix protein by SUMO.
Baz-Martínez M; El Motiam A; Ruibal P; Condezo GN; de la Cruz-Herrera CF; Lang V; Collado M; San Martín C; Rodríguez MS; Muñoz-Fontela C; Rivas C
Sci Rep; 2016 Nov; 6():37258. PubMed ID: 27849047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
